Poster (Scientific congresses and symposiums)
Caveolar proteins : putative FSHD biomarkers
Wauters, Armelle; Tassin, Alexandra; Leroy, Baptiste et al.
2015EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease
 

Files


Full Text
Poster Armelle WAUTERS.pdf
Publisher postprint (1.44 MB)
Request a copy

All documents in ORBi UMONS are protected by a user license.

Send to



Details



Abstract :
[en] Facioscapulohumeral muscular dystrophy (FSHD) is linked to chromatin opening and DNA hypomethylation at the D4Z4 repeat array in the 4q35 subtelomeric region. The open chromatin facilitates the expression of the DUX4 gene located in the last D4Z4 unit. The DUX4 protein is a potent transcription factor that initiates a deregulation cascade affecting many genes and that causes the disease1. We have previously compared the proteome of primary FSHD and control myotubes at day 4 of differentiation2. FSHD myotubes presented a disturbance of two major caveolar proteins: PTRF (cavin-1) and MURC (cavin-4). Caveolae are membrane nanodomains, considered as a subset of lipid rafts, enriched in cholesterol and sphingolipids. They play a major role in signal transduction for many biological processes. Caveolae contain the muscle specific caveolin (caveolin-3) and small clusters of GPI-anchor proteins, also increased in FSHD myotubes. The extracellular protein AHNAK, a member of the dysferlin protein complex, is also slightly increased in FSHD myotubes. To evaluate the FSHD caveolar defect, we have investigated the expression of the four cavin proteins (PTRF, SDPR, SRBC, MURC) by immunodetection on western-blot and immunofluorescence on myotubes. We have validated the disturbance of PTRF and MURC expression on FSHD primary myoblasts and myotubes2 (kindly provided by Prof. D. Laoudj-Chenivesse, INSERM U1046, Montpellier). Because primary myoblasts are in limited supply we have switched to immortalized control and FSHD cell lines3 (kindly provided by Dr. Ch. Emerson, Wellstone Foundation, Boston) for further studies. We also use mouse myoblast lines with inducible DUX44 (iC2C12-DUX4, kindly provided by Prof. M. Kyba, Univ. Minnesota), to evaluate the correlation between DUX4 expression and caveolar protein disturbance. We have performed these immunodetections on western-blots with myoblast/tube total extracts and on isolated lipid raft extracts. We are also studying the putative relocations of these rafts during differentiation with a lipid raft tracer: FITC-conjugated cholera toxin B subunit. If caveolar dysfunction was confirmed in FSHD, deregulation of MURC and PTRF that are essential for skeletal muscle membrane stability could lead to deregulation of many cellular processes. In addition, if a link with DUX4 can be demonstrated, these proteins could be used as additional FSHD biomarkers. Identification of such markers and their validation is essential to assess the therapeutic approaches developed by several groups to decrease DUX4 expression such as antisense tools used in our laboratory5 in collaboration with Prof. S. Wilton (Murdoch University, Australia).
Research center :
CREMH - Mind & Health
Disciplines :
General & internal medicine
Author, co-author :
Wauters, Armelle ;  Université de Mons > Faculté de Médecine et de Pharmacie > Biochimie métabolique et moléculaire
Tassin, Alexandra  ;  Université de Mons > Faculté de Médecine et de Pharmacie > Physiologie et réadaptation respiratoire
Leroy, Baptiste  ;  Université de Mons > Faculté des Sciences > Protéomie et Microbiologie
Laval, Steven
Wattiez, Ruddy  ;  Université de Mons > Faculté des Sciences > Service de Protéomie et Microbiologie
Belayew, Alexandra ;  Université de Mons > Faculté de Médecine et de Pharmacie > Biochimie métabolique et moléculaire
Language :
English
Title :
Caveolar proteins : putative FSHD biomarkers
Publication date :
21 September 2015
Number of pages :
1
Event name :
EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease
Event place :
Ascona , Unknown/unspecified
Event date :
2015
Research unit :
M122 - Biochimie métabolique et moléculaire
Research institute :
R550 - Institut des Sciences et Technologies de la Santé
Available on ORBi UMONS :
since 15 January 2016

Statistics


Number of views
4 (0 by UMONS)
Number of downloads
0 (0 by UMONS)

Bibliography


Similar publications



Contact ORBi UMONS